Incyte (INCY) Misses Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $124.97 -1.4%
EPS Growth %: -225.2%
Financial Fact:
Contract revenues: 3.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -225.2%
Financial Fact:
Contract revenues: 3.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q4 EPS of ($0.22), $0.13 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $106 million versus the consensus estimate of $138.37 million.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- HSBC lifts S&P 500 year-end target
- Freeport-McMoRan shares surge as copper hits record $14,694/ton
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
